glp 1 gip glucagon triple agonist retatrutide mechanism glp-1 GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation Upcoming wave of hormone-based therapies
Description
A total of 63.2% of the patients in the liraglutide arm lost at least 5% of their body weight compared with 27.1% in the placebo arm ( P 30% (79)
Mounjaro, and other weight loss injections, like Ozempic and Wegovy, are similar
93 Based on mouse models, where the glucagon gene was disrupted by the insertion of green fluorescent protein, abolishing the synthesis of its products, including GLP-1
Glucagon-Like peptide-1 receptor agonists
They both play important roles in lowering inflammation, maintaining metabolism, and balancing hormones and blood sugar
